Clinical Trial Update: Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC [Phase 3]

View source ↗

Summary

A Phase III trial evaluating Envafolimab plus chemotherapy versus placebo plus chemotherapy in resectable stage III non-small cell lung cancer is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Envafolimab (envafolimab)

Snippet

Sponsor: 3D Medicines (Sichuan) Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: RECRUITING